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Abstract
Background and Objectives: One of the irnporlant requirernents for non-viral gene deliverr
systems is to achieve high levels of transf-ection efficiency by overcoming extracellular and
intracellular barriers. Despite extensive eftbrts. several obstacles inipede successful application
of viral and non- viral delivery strategies. The aim of current study was to design and
characterize a clelivery device for genes. based on reconstitution of VSV virus envelope
glycoprotein (VSV-G) in to the niosome nrerrbrane in order to combine the advantages of viral
and non-viral vectors. In many studies, niosomes are used for drug delivery or gene transfer.
However. their properties and features relative to liposomes are not well documented. Another
rvay to increase the efficacy of gene clelivery is condensing of DNA by cationic peptides. D//l
condensqtio,rz leads to protection of DNA against extracellular nuclease degradation.
Furthermore, through insertion o1'NLS signal to noted peptides. their nuclear trafficking are
intproved. In brief, the aim of current study was gene deliverl b1' niosomal virosomes in 1it
yilro model of Parkir-rsotr disease.
Methods: Firstly. to characterize and more ratior.tally optilnize niosome forntulations, the
properlies of these vesicle systems are compared to sirnilar liposomes b1 biophl'sical and
biochemical assays. Then, the irnpact of cholesterol on biophysical and biochentical properties
of niosonte was investigated. As first step to reconstitute VSV- G, the solubilization of
niosomes by Triton X-100 (TR) in presence and absence of cholesterolrvas done. To improve
transfection efficiency, a multi-don-rain fusion protein including nuclear localization motif
0\iLS) and trvo DNA-binding (Mu) dornains, namely NLS-Mu-Mu NMM) has been designed.
cloned and expressed in E. coli DE3 strain. DNA condensing properlies of NMM and protamine
rvere evaluated by various experiments. Fufthermore, we examirted the potential of recombinant
protein to condense and protect DNA against nuclease as well as their cytotoxicity, hemolysis.
and transfection potential in HEK293T and MCF-7 cell lines. In the next step. VSV-G ploteitr
was expressed in HEK293T and partialty purified. Then it reconstituted in to the STSOCFI
niosomes. Finalll'. an in vitro model of Parl<inson's \yas generated in SH-SY5Y cells line and
the potential of designed niosomal VSV-G virosome to transfer the GDNF plasmid rvas
evaluated"
Results: Niosomes are higlill' stable but only sliglrtly leakier than liposolres as assayed b1'
calcein leakage. Fuftlrermore, the permeability of niosome for protons is higher than that of
liposornes" The packing of niosomal mernbranes is slightly lowerthan that of liposornes.'fhe
peptides alamethicin and melittin act sinrilarly on both vesicular systelns. Our results indicated
tlrat cholesterol in niosomes increases nrerrbrane stabiliq decreases the f-lurdiir ;. .
membrane. We shorved that cholesterol-containing rriosonres needed higher arnollnt r-. -.
concentration for solubilization. VSV-C reconstitution was done successfulll in niLrsL-:t..
membrane and the transfection efficiency n as assessed by reporter gene expression in HEK:'-:
and IVICF-7 cell lines. The recombinantNMM was expressed and purified successfulll. It *;.s
observed that the recombinant NMM is able to condense DNA, protect it from nuclease ar:;
increase transfection efficiency of reporter gene. Finally, VSV-G niosornal virosome containing
condensed GDNF plasrnid with NMM protein had gene transfer ability to in vitro model ti
Parkinson disease.
Conclusion: In various biophysical and biochemical aspects, niosomes are comparable tc,
liposomes and they may offer an excellent. inexpensive alternative for delivery purposes. \\:
have demonstrated for the first tinre that the reconstituted VSV-G niosomal virosomes ar.
efficient vehicles for the deliverl' of forei"n genes into hurnan neuroblastoma cells (SH-SY5\-
as a model of Parkinson disease.
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